Attention Training for COVID-19 Related Distress
Not Applicable
Terminated
- Conditions
- Anxiety
- Registration Number
- NCT06267313
- Lead Sponsor
- Palo Alto University
- Brief Summary
The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
- COVID-19 Anxiety Syndrome Scale > 7 and/or COVID-19 related loss
Exclusion Criteria
- Does not speak English Fluently
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method COVID-19 Anxiety Syndrome Scale 105 days The measure is scored using a 5-point time anchored scale (0 = Not at all to 4 = Nearly every day over the last 2 weeks) and scores range between 0 and 20, with higher scores reflecting worse outcome.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie attention bias modification in reducing anxiety symptoms post-COVID-19?
How does attention control training compare to cognitive behavioral therapy for managing pandemic-related distress?
Are there specific biomarkers that predict response to attention training interventions in anxiety disorders?
What are the potential adverse events associated with attention bias modification techniques in clinical populations?
What combination therapies show synergistic effects with attention training for treating post-viral anxiety syndromes?
Trial Locations
- Locations (1)
Palo Alto University
🇺🇸Palo Alto, California, United States
Palo Alto University🇺🇸Palo Alto, California, United States